FreeStyle Libre’s flash glucose monitoring system improves control in people with Type 1 diabetes during the first six months of use, says a nationwide audit.
Three years of follow-up from the COMISAIR study has found that glycemic outcomes in adults with T1D are impacted more by continuous glucose monitoring than
Beta Bionics, based in the US, has announced the first patients have begun home use of dasiglucagon – a stable glucagon analogue – in a clinical
Abbott and Sanofi are partnering to integrate glucose sensing and insulin delivery technologies that would help to further simplify how people with diabetes manage their
A company developing and manufacturing advanced wearable infusion devices has entered into a multi-product development agreement with insulin supplier Sanofi. Developed and manufactured by Enable
Diabetes UK has called for the Government not to water down plans to introduce mandatory calorie labelling in restaurant, cafe and takeaway chains, which could
A son has dedicated his university studies to create an acceptable alternative to sugar to help his father and millions of other Mexicans. Javier Larragoiti
Scotland agrees that the current levels of children’s exposure to junk food advertising is unacceptable, with a survey conducted in June 2019 from Obesity Action
The U.S. Food and Drug Administration (FDA) has approved Baqsimi (glucagon) nasal powder 3mg for the treatment of severe hypoglycemia in people with diabetes ages
Three primary care organisations have been announced as the joint winners of a competition to enable healthcare professionals to offer their patients with Type 2 diabetes
